2,167
Views
45
CrossRef citations to date
0
Altmetric
Research Article

SPECT/CT imaging of chemotherapy-induced tumor apoptosis using 99mTc-labeled dendrimer-entrapped gold nanoparticles

, , , , , , , & show all
Pages 1384-1393 | Received 21 Mar 2018, Accepted 07 May 2018, Published online: 05 Jun 2018

References

  • Brindle K. (2008). New approaches for imaging tumour responses to treatment. Nat Rev Cancer 8:94–107.
  • Chen Q, Li K, Wen S, et al. (2013). Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles. Biomaterials 34:5200–9.
  • Cheng Y, Zhu J, Zhao L, et al. (2016). 131I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. Nanomedicine 11:1253–66.
  • Delbeke D, Schöder H, Martin WH, et al. (2009). Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med 39:308–40.
  • Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–47.
  • Elvas F, Boddaert J, Vangestel C, et al. (2017). 99mTc-duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET. J Nucl Med 58:665–70.
  • Elvas F, Vangestel C, Pak K, et al. (2016). Early prediction of tumor response to treatment: preclinical validation of 99mTc-duramycin. J Nucl Med 57:805–11.
  • Garin E, Lenoir L, Rolland Y, et al. (2012). Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 53:255–63.
  • Goffin J, Baral S, Tu D, et al. (2005). Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval. Clin Cancer Res 11:5928–34.
  • Kao YH, Hock Tan AE, Burgmans MC, et al. (2012). Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med 53:559–66.
  • Koh G, Hwang KH, Lee H, et al. (2016). Correlation of uptake patterns on single-photon emission computed tomography/computed tomography (SPECT/CT) and treatment response in patients with knee pain. Nucl Med Mol Imaging 50:137–43.
  • Li L, Gao F, Jiang W, et al. (2016). Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Drug Deliv 23:1726–33.
  • Li X, Xiong Z, Xu X, et al. (2016). 99mTc-labeled multifunctional low-generation dendrimer-entrapped gold nanoparticles for targeted SPECT/CT dual-mode imaging of tumors. ACS Appl Mater Interfaces 8:19883–91.
  • Lin FI, Huang EP, Shankar LK. (2017). Beyond correlations, sensitivities, and specificities: case examples of the evaluation of advanced imaging in oncology clinical trials and cancer treatment. Acad Radiol 24:1027–35.
  • Luo R, Niu L, Qiu F, et al. (2016). Monitoring apoptosis of breast cancer xenograft after paclitaxel treatment with 99mTc-labeled duramycin SPECT/CT. Mol Imaging 15:1536012115624918.
  • Luo Y, Zhao L, Li X, et al. (2016). The design of a multifunctional dendrimer-based nanoplatform for targeted dual mode SPECT/MR imaging of tumors. J Mater Chem B 4:7220–5.
  • Mariani G, Bruselli L, Kuwert T, et al. (2010). A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 37:1959–85.
  • Palmedo H, Marx C, Ebert A, et al. (2014). Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging 41:59–67.
  • Qiao Z, Shi X. (2015). Dendrimer-based molecular imaging contrast agents. Prog Polym Sci 44:1–27.
  • Vaidya M, Creach KM, Frye J, et al. (2012). Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. Radiother Oncol 102:239–45.
  • Wang R, Luo Y, Yang S, et al. (2016). Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma. Sci Rep 6:33844.
  • Wang S, Zhao J, Yang H, et al. (2017). Bottom-up synthesis of WS2 nanosheets with synchronous surface modification for imaging guided tumor regression. Acta Biomater 58:442–54.
  • Wang Z, Xuan S, Qiu W, et al. (2017). Near infrared light mediated photochemotherapy for efficiently treating deep orthotopic tumors guided by ultrasound imaging. Drug Deliv 24:1441–52.
  • Wei P, Chen J, Hu Y, et al. (2016). Dendrimer-stabilized gold nanostars as a multifunctional theranostic nanoplatform for CT imaging, photothermal therapy, and gene silencing of tumors. Adv Healthc Mater 5:3203–13.
  • Wen S, Li K, Cai H, et al. (2013). Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials 34:1570–80.
  • Wen S, Zhao L, Zhao Q, et al. (2017). A promising dual mode SPECT/CT imaging platform based on 99mTc-labeled multifunctional dendrimer-entrapped gold nanoparticles. J Mater Chem B 5:3810–5.
  • Xing Y, Zhao J, Conti PS, et al. (2014). Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics 4:290–306.
  • Xiong Z, Wang Y, Zhu J, et al. (2017). Dendrimers meet zwitterions: development of a unique antifouling nanoplatform for enhanced blood pool, lymph node and tumor CT imaging. Nanoscale 9:12295–301.
  • Xu X, Zhao L, Li X, et al. (2017). Targeted tumor SPECT/CT dual mode imaging using multifunctional RGD-modified low generation dendrimer-entrapped gold nanoparticles. Biomater Sci 5:2393–7.
  • Zhao L, Shi X, Zhao J. (2017). Dendrimer-based contrast agents for PET imaging. Drug Deliv 24:81–93.
  • Zhao L, Zhu J, Cheng Y, et al. (2015). Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 131I for single photon emission computed tomography imaging and radiotherapy of gliomas. ACS Appl Mater Interfaces 7:19798–808.
  • Zhao L, Zhu M, Li Y, et al. (2017). Radiolabeled dendrimers for nuclear medicine applications. Molecules 22:1350.
  • Zhou B, Xiong Z, Wang P, et al. (2018). Targeted tumor dual mode CT/MR imaging using multifunctional polyethylenimine-entrapped gold nanoparticles loaded with gadolinium. Drug Deliv 25:178–86.